Targeting CXCR2 signaling in inflammatory lung diseases: neutrophil-driven inflammation and emerging therapies

Hussain, MS; Goyal, A; Goyal, K; S., RJ; Nellore, J; Shahwan, M; Rekha, A; Ali, H; Dhanasekaran, M; MacLoughlin, R; Dua, K; Gupta, G

Targeting CXCR2 signaling in inflammatory lung diseases: neutrophil-driven inflammation and emerging therapies

Hussain, MS Goyal, A Goyal, K S., RJ Nellore, J Shahwan, M Rekha, A Ali, H Dhanasekaran, M MacLoughlin, R Dua, K

Gupta, G

Permalink

Publisher:: Springer Science and Business Media LLC
Publication Type:: Journal Article
Citation:: Naunyn-Schmiedeberg's Archives of Pharmacology

Closed Access

	Filename	Description	Size
	Targeting CXCR2 signaling in inflammatory lung diseases_ neutrophil-driven inflammation and emerging therapies.pdf	Published version	1.71 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Hussain, MS
dc.contributor.author	Goyal, A
dc.contributor.author	Goyal, K
dc.contributor.author	S., RJ
dc.contributor.author	Nellore, J
dc.contributor.author	Shahwan, M
dc.contributor.author	Rekha, A
dc.contributor.author	Ali, H
dc.contributor.author	Dhanasekaran, M
dc.contributor.author	MacLoughlin, R
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.contributor.author	Gupta, G
dc.date.accessioned	2025-03-08T13:32:17Z
dc.date.available	2025-03-08T13:32:17Z
dc.identifier.citation	Naunyn-Schmiedeberg's Archives of Pharmacology
dc.identifier.issn	0028-1298
dc.identifier.issn	1432-1912
dc.identifier.uri	http://hdl.handle.net/10453/185588
dc.language	en
dc.publisher	Springer Science and Business Media LLC
dc.relation.ispartof	Naunyn-Schmiedeberg's Archives of Pharmacology
dc.relation.isbasedon	10.1007/s00210-025-03970-x
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1115 Pharmacology and Pharmaceutical Sciences, 1116 Medical Physiology
dc.subject.classification	Pharmacology & Pharmacy
dc.subject.classification	3214 Pharmacology and pharmaceutical sciences
dc.title	Targeting CXCR2 signaling in inflammatory lung diseases: neutrophil-driven inflammation and emerging therapies
dc.type	Journal Article
utslib.for	1115 Pharmacology and Pharmaceutical Sciences
utslib.for	1116 Medical Physiology
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
pubs.organisational-group	University of Technology Sydney/UTS Groups
pubs.organisational-group	University of Technology Sydney/UTS Groups/Centre for Inflammation (CFI)
pubs.organisational-group	University of Technology Sydney/UTS Groups/Centre for Inflammation (CFI)/Centre for Inflammation (CFI) Associate Members
pubs.organisational-group	University of Technology Sydney/UTS Groups/Australian Research Consortium in Complementary and Integrative Medicine (ARCCIM)
pubs.organisational-group	University of Technology Sydney/UTS Groups/Stroke Research Collaborative
utslib.copyright.status	closed_access	*
dc.date.updated	2025-03-08T13:32:14Z
pubs.publication-status	Published online

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/185588